Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7235 p177-181
8 February 2003


News summary

Research & Development  |  Branch meetings   Future Events   Conferences 

177 Hospital pharmacists and technicians to be covered by NHS pay review body Further documents issued by the Department of Health as part of negotiations on the "Agenda for change" pay scheme confirm that pharmacists are to come under the remit of the National Health Service pay review body for nurses and professions allied to medicine...[more]

177 Welsh Assembly considers wider prescription charge exemptions The National Assembly for Wales is to consider extending exemption from paying prescription charges to all patients with chronic life-long illnesses...[more]

177 Dispensing robots for Lloydspharmacy Lloydspharmacy is to introduce robotic dispensing into its pharmacies...[more]

177 Vigilance required with methotrexate labels, says CSM Pharmacists have been advised by the Department of Health to be vigilant in ensuring that dispensing labels for oral methotrexate products accurately reflect the intended dosage...[more]

178 NPA to produce local campaigns pack to help pharmacists oppose OFT report Members of the National Pharmaceutical Association are to receive campaign packs to help them take action at local level to stimulate opposition to the implementation of the recommendation in the Office of Fair Trading report...[more]

178 Warning: poor handwriting can kill The chief medical officer, Sir Liam Donaldson, has written to doctors warning them of the potential for medication errors arising from illegible handwriting...[more]

178 Boots / Sainsbury’s end “store within a store” collaboration Boots and Sainsbury's are to end their "store within a store" trial, which has been operating in nine Sainsbury's stores since October 2001...[more]

179 Study confirms benefit of intensive therapy in type 2 diabetes mellitus Intensive therapy, including lifestyle and drug interventions, in the management of type 2 diabetes reduces the risk of cardiovascular and microvascular events by about 50 per cent compared with conventional treatment, report Danish researchers...[more]

179 Change of image revealed for PHS The Pharmacy Healthcare Scheme has changed its name to PharmacyHealthLink...[more]

179 Aspirin reminder Pharmacy superintendents have been asked to ensure that staff use point-of-sale materials supplied by manufacturers that publicise the information that aspirin should not be given to children under 16 years...[more]

179 Guidance issued by pharmacist on how to administer medicines to patients with swallowing difficulties Guidance for nurses and carers who administer medicines to patients with swallowing difficulties has been produced by Dr David Wright, lecturer in pharmacy practice at the University of Bradford...[more]

180 Placebo effect for homoeopathic arnica New research showing homoeopathic arnica has no effect on pain or bruising after hand surgery will "help people save money" by not buying this remedy, according to a professor of complementary medicine...[more]

180 Consider combined salmeterol/fluticasone in COPD Combination inhaled therapy with salmeterol and fluticasone should be considered for some patients with chronic obstructive pulmonary disease (COPD), according to data...[more]


Research and Development


181 Cytokine may provide new approach to managing sepsis in cancer patients Treatment with recombinant human interleukin 11 (rhIL-11) reduces the frequency and load of bacteraemia in patients with haemological malignant disease receiving chemotherapy, researchers say...[more]

181 Vampire bat saliva component is promising treatment for stroke A plasminogen activator found in the saliva of a blood-feeding vampire bat (Desmodus rotundus) is a promising treatment for patients with ischaemic stroke, a new study shows...[more]

181 Drug harnesses positive effects of thalidomide to destroy cancer cells A compound related to thalidomide could prove to be an effective anticancer agent because of its ability to induce apoptosis, say researchers...[more]

181 Engineered anthrax toxin has efficacy against tumours An anthrax toxin that has broad and potent antitumour activity but exerts limited toxicity to normal tissue has been produced by American researchers...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal